融合成像用于肺动脉栓塞术:对透视时长和对比剂暴露的影响
回顾性纳入34例连续接受肺动脉栓塞术的患者(肺动脉动静脉畸形28例、咯血6例),融合成像组15例采用2D/3D配准融合成像引导,对照组19例未使用融合成像。融合组栓塞所用对比剂平均体积118.3 ml显著低于对照组285.3 ml(p < 0.002),两组平均透视时长无显著差异(融合组19.5 min vs 对照组31.4 min,p = 0.10),平均X线暴露(Air Kerma)无显著差异(单变量分析p = 0.68),两组技术成功率均为100%。
要点
- 融合组成像引导下肺动脉栓塞对比剂用量显著低于对照组(118.3 ml vs 285.3 ml,p < 0.002)。
- 两组透视时长无显著差异(融合组19.5 min vs 对照组31.4 min,p = 0.10)。
- 两组技术成功率均为100%,平均X线暴露(Air Kerma)无显著差异(p = 0.68)。
核心结论
- 融合成像显著减少肺动脉栓塞术所需的对比剂体积,透视时长和X线暴露无显著变化。
研究设计与样本
- 回顾性纳入34例连续接受肺动脉栓塞术的患者(肺动脉动静脉畸形28例、咯血6例),融合成像组15例采用2D/3D配准融合成像引导,对照组19例未使用融合成像。
诊断标准与关键数值
- 融合组栓塞所用对比剂平均体积118.3 ml,对照组285.3 ml,融合组显著低于对照组(p < 0.002)。
- 融合组平均透视时长19.5 min,对照组31.4 min,两组无显著差异(p = 0.10)。
- 平均X线暴露(Air Kerma)两组无显著差异(单变量分析p = 0.68)。
- 两组技术成功率均为100%。
临床应用与阅片要点
- 基于CTA的2D/3D配准融合成像有助于肺动脉栓塞术的规划与导管引导,并减少对比剂用量。
- 融合成像组与对照组在透视时长和X线暴露上无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the impact of fusion imaging guidance on fluoroscopy duration and volume of contrast agent used for pulmonary artery embolization.
METHODS: Thirty-four consecutive patients who underwent pulmonary artery embolization for pulmonary arterio-venous malformation (n = 28) or hemoptysis (n = 6) were retrospectively included. In the experimental group (n = 15), patients were treated using fusion imaging with 2D/3D registration. In the control group (n = 19), no fusion imaging has been used. Fluoroscopy duration and amount of contrast used were measured and intergroup comparison was performed.
RESULTS: The average volume of contrast agent used for embolization in the fusion group (118.3 ml) was significantly lower than in the control group (285.3 ml) (p < 0.002). The mean fluoroscopy duration was not significantly different between both groups (19.5 min in the fusion group vs 31.4 min in the control group (p = 0.10)). No significant difference was observed regarding the average X-ray exposure (Air Kerma) (p = 0.68 in the univariate analysis). Technical success rate was 100% for both groups.
CONCLUSION: Fusion imaging significantly reduces contrast medium volumes needed to perform pulmonary artery embolization. The fluoroscopy duration and the X-ray exposure did not vary significantly.
ADVANCES IN KNOWLEDGE: CTA-based fusion imaging using 2D-3D registration is a valuable tool for performing pulmonary artery embolization, helpful for planning and guiding catheterization.Compared to the traditional imaging guidance, fusion imaging reduces the volume of contrast agent used.
引用
- Garnier M, Curado A, Grancher A, et al. Fusion imaging for pulmonary artery embolization: impact on fluoroscopy duration and contrast agent exposure. Br J Radiol. 2023. PMID: 37660369. doi:10.1259/bjr.20220815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。